Adimab - 搜索

约 14,100 个结果

在新选项卡中打开链接

Adimab
https://adimab.com
Homepage - Adimab
Adimab is a company that provides antibodies and multispecifics for therapeutic development, using a proprietary yeast-based platform. Learn more about Adimab's technology, partnering, …
来自adimab.com的其他内容
展开
Adimab
https://adimab.com › technology
Technology - Adimab
Adimab is a biotechnology company that uses a proprietary yeast strain and synthetic libraries to discover and engineer antibodies against diverse targets. Adimab offers library-to-lead workflows, analytical profiling, developability …
- Partnering
  Contact
  Technology
  News & Press Releases
  Open Positions
  Adimab Announces Antibody Discovery Platform Transfer with Takeda
Adimab
https://adimab.com › platform
Platform - Adimab
Adimab is a company that offers de novo antibody discovery and optimization, engineering of antibody, TCR, and other therapeutic proteins, and multispecific technologies. Adimab uses a proprietary yeast-based platform and AI and ML …
知乎专栏
https://zhuanlan.zhihu.com
酵母展示技术在抗体发现中的应用 - 知乎 - 知乎专栏
Adimab的核心技术是利用酵母平台进行抗体发现和抗体成熟工程。 Adimab是全球唯一拥有商业化人源全长抗体库酵母展示技术平台的公司，独特的酵母技术使得Adimab成为了抗体药开发领域的独角兽企业，凭借这一特点，Adimab与各 …
ONO PHARMACEUTICAL CO., LTD.
https://www.ono-pharma.com › en › news
Ono Enters into a Drug Discovery Collaboration Agreement with …
2023年9月27日 · Ono Pharmaceutical Co., Ltd. and Adimab, LLC have entered into a drug discovery collaboration agreement to discover and develop novel antibody drugs for cancers. …
智慧芽新药情报库
https://synapse.zhihuiya.com › organization
Delving into the Latest Updates on Adimab LLC with Synapse
2023年5月1日 · 了解Adimab LLC (Adimab LLC)公司的药物管线，治疗领域，技术平台，以及它的586篇新闻和55篇文献，疾病领域:肿瘤，感染，内分泌与代谢疾病，神经系统疾病，免疫系统 …
其他用户还问了以下问题
How does Adimab work?
Adimab has optimized over a thousand individual antibodies on the basis of specificity, potency, and/or developability. This robust process relies on AI and ML-guided library diversities, facile library incorporation into our yeast strain, and the ability to enrich towards optimized properties with real-time feedback from flow cytometry.
Technology - Adimab
adimab.com
Who is Adimab?
Adimab is more than a company. We are a community of people who care for one another. Adimab is the leading provider of biologics discovery and engineering, with a core competency in antibodies and multispecifics, generating more than 500 therapeutic programs over 15 years of industry partnerships.
Homepage - Adimab
adimab.com
What makes Adimab a successful antibody discovery company?
Adimab is the most successful antibody discovery company in the industry, with 450+ discovery campaigns and 55+ clinical programs created with more than 100 partners. Our unique, yeast-based platform is a comprehensive and effective tool for the discovery and optimization of fully human monoclonal and bispecific antibodies.
Adimab | LinkedIn
linkedin.com
What are Adimab projects?
Adimab projects consist of IgG and HCAb discovery, engineering of protein-based therapeutics, and the generation of multispecifics, including a robust T cell engager platform. Adimab is more than a company. We are a community of people who care for one another.
Homepage - Adimab
adimab.com
What makes Adimab unique?
Adimab’s best-in-class therapeutic discovery capabilities are made possible by our proprietary yeast-based platform, utilizing fully human synthetic diversity and immunized diversity to generate IgGs, single domain antibodies (HCAbs), and multispecific leads with remarkable specificity and developability profiles.
Homepage - Adimab
adimab.com
How many followers does Adimab have?
Adimab | 5,702 followers on LinkedIn. Premier Human Antibody Discovery and Engineering Company | Adimab is the most successful antibody discovery company in the industry, with 450+ discovery campaigns and 55+ clinical programs created with more than 100 partners.
Adimab | LinkedIn
linkedin.com
反馈
LinkedIn
https://www.linkedin.com › company › adimab-llc
Adimab - LinkedIn
Premier Human Antibody Discovery and Engineering Company | Adimab is the most successful antibody discovery company in the industry, with 600+ discovery campaigns and 75+ clinical …
BioSpace
https://www.biospace.com › press-releases › adimab...
Adimab Provides Update on Pipeline - BioSpace
2025年1月14日 · Adimab’s integrated antibody discovery and engineering platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers …
Yahoo Finance
https://finance.yahoo.com › news
Adimab Provides Year-End Update on 2024 Partnership Activities
LEBANON, N.H., January 13, 2025--(BUSINESS WIRE)--Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, today …
Adimab
https://adimab.com › who-we-are
Who We Are - Adimab
Adimab is a biotechnology company that develops therapeutic antibodies for over 115 partners, including pharma, biotech, and academic institutions. With over 15 years of experience and 70 clinical programs, Adimab has a proven track …
其他用户还搜索过
Adimab 的相关搜索
分页
- 1
- 2
- 3
- 4
- 下一页